Ablitech, Inc.
| Industry | Biotechnology |
|---|---|
| Founded | 2006 |
| Founder | Dr. Lisa Kemp Dr. Nick Hammond Dr. Kenneth Malone |
| Headquarters | Baltimore, Maryland |
Ablitech, Inc. is a biotechnology company founded in Hattiesburg, Mississippi, that specializes in the development and commercialization of platform technologies that heal and protect the human body.[1] The corporation relocated to Baltimore, Maryland in early 2012 and is located at the University of Maryland BioPark.[2]
History
Ablitech was co-founded in 2006 by Dr. Lisa Kemp, Dr. Nick Hammond and Dr. Kenneth Malone on technology licensed from The University of Southern Mississippi.
The formation of Ablitech was a direct result of the National Science Foundation program IGERT – an “interdisciplinary training program, educating U.S. Ph.D. scientists and engineers by building on the foundations of their disciplinary knowledge with interdisciplinary training.”[3][4][5]
In 2007, Ablitech received a SBIR Phase I for the development of a bio-transformable drug-eluting coronary stent.[6] Then in 2008 they received another SBIR Phase I for the development of a cancer therapy.[7]
Ablitech received the Mississippi Seed Fund Research and Development investment in 2009 and in 2010.[8] Managed by the Mississippi Technology Alliance, the Mississippi Seed Fund provides high-tech, start-up companies with access to pre-seed financing, early stage risk capital, and product development capital to stimulate and accelerate the development of high-performance, technology-based business ventures in Mississippi.[9]
In 2011, Ablitech received a $2 million grant from the Department of Defense to develop a siRNA based therapy for heterotopic ossification.[10]
Research
Ablitech's signature product, VersadelTM, is a nucleic acid platform delivery technology that “provides a non-toxic, biocompatible method for the systemic and local delivery of antisense DNA and siRNA in the body.” [11]
Awards
References
- ↑ Ablitech’s Mission Statement. Retrieved 1/07/2011: http://www.ablitech.com.
- ↑ "Ablitech: Mississippi biotech startup moves to University of Maryland BioPark". tribunedigital-baltimoresun. Archived from the original on 2015-10-17. Retrieved 2026-08-05.
- ↑ "News | NSF - U.S. National Science Foundation". www.nsf.gov. 2026-08-03. Retrieved 2026-08-05.
- ↑ Mississippi Gulf Coast Alliance for Economic Development. 2009. Could Ablitech Change Cancer Treatment? Retrieved 1/07/2011: http://www.mscoastaerospace.com/files/q109_newsletter.pdf Archived 2011-07-14 at the Wayback Machine.
- ↑ IGERT – About IGERT. Retrieved 1/07/2011: http://www.igert.org/public/about Archived 2011-07-22 at the Wayback Machine.
- ↑ "Noetic Technologies News: Ablitech Inc. Receives $100,000 NSF Grant". www.noetictechnologies.org. Archived from the original on 2012-03-16. Retrieved 2026-08-05.
- ↑ Research Watch. SBIR Phase I: PolyRNA –A Radical Innovation for Healing the Human Body. Retrieved 1/07/2011: http://researchwatch.net/nsf_grants/0810755.
- ↑ Northway, Wally. 2010. Ablitech receives more ‘Seed’ money from MTA. The Mississippi Business Journal. Retrieved 1/07/2011: http://msbusiness.com/blog/2010/06/ablitech-receives-more-seed-money-from-mta/.
- ↑ "Seed Fund". www.technologyalliance.ms. Archived from the original on 2014-01-08. Retrieved 2026-08-05.
- ↑ "Ablitech Gets $2M DoD Grant for R&D into Heterotopic Ossification | GEN News Highlights | GEN". GEN. Archived from the original on 2016-03-03. Retrieved 2026-08-05.
- ↑ Wbt Innovation Marketplace. 2010. Company Profiles: Ablitech, Inc. Retrieved 10/19/2010: http://www.wbtshowcase.com/wbt/web.nsf/pages/files.html/$file/WBT2011%20Profile%20-%20Ablitech%20Inc.pdf.
- ↑ "IYF hall of fame". www.noetictechnologies.com. Archived from the original on 2012-03-16. Retrieved 2026-08-05.
- ↑ The University of Memphis - FedEx Institute of Technology. 2006. NanoTect Takes Top Prize in Mid-South Business Plan Competition. Retrieved 1/07/2011: http://www.memphis.edu/fedex/releases/2006/4-04-06BusinessFInal.php Archived 2010-06-06 at the Wayback Machine.